Illumina has struck a $60 million deal to enhance its genetic sequencing technology with the acquisition of Avantome. Avantome's owners will get $25 million of that upfront with the rest coming in contingency payments. And company founders Mostafa Ronaghi and Helmy Eltoukhy say they will take a place in Illumina's management team.
- read the AP story [1]
Related Articles:
Illumina offers understanding of molecular mechanisms [2]
Illumina focuses on molecular diagnostics [3]
Four companies lead genome sequencing race [4]
Illumina to buy Solexa for $600M [5]
Links:
[1] http://money.cnn.com/news/newsfeeds/articles/apwire/c739d196d823d34b658cab7225773e95.htm
[2] http://www.fiercebioresearcher.com/story/illumina-offers-understanding-of-molecular-mechanisms/2008-04-15?utm_medium=rss&utm_source=bioresearcher_RNA&cmp-id=OTC-RSS-FBR0
[3] http://www.fiercebiotech.com/story/illumina-focuses-molecular-diagnostics/2008-01-04
[4] http://www.fiercebioresearcher.com/story/four-companies-lead-genome-sequencing-race/2007-10-09
[5] http://www.fiercebiotech.com/story/illumina-to-buy-solexa-for-600m/2006-11-13